Recent News

• 04.08.2026 - Biora Therapeutics Advances BioJet™ Swallowable Autoinjector
• 03.31.2025 - Biora Therapeutics Successfully Completes Restructuring Process
• 12.30.2024 - Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
• 11.14.2024 - Biora Therapeutics Q3 2024 Financial Results Conference Call
• 11.14.2024 - Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
• 11.07.2024 - Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Recent Filings

• 08.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.04.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 03.26.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.30.2024 - EX-99.1 EX-99.1
• 12.30.2024 - 8-K Current report
• 12.16.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.10.2024 - 8-K Current report
• 11.15.2024 - 8-K Current report